Clinical Trials on Extravascular Lung Water in China

Total 5103 results

Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study

Non Small Cell Lung Cancer

China
Peking Union Medical College Hospital
AstraZeneca

Recruiting

Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial (AUTUMN)

Non Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer

Small-cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Non Small Cell Lung Cancer

China
Peng Zhang

Recruiting

Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage

Small-cell Lung Cancer

China
Guangdong Association of Clinical Trials
Peking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaborators

Unknown

Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation (ADJUVANT)

Non-small Cell Lung Cancer

China
Xinqiao Hospital of Chongqing

Unknown

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Southwest Hospital, China

Unknown

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Centaurus Biopharma Co., Ltd.

Unknown

Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR

Non-small Cell Lung Cancer

China
Peking University People's Hospital

Unknown

Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients (NSCLC)

Non-small Cell Lung Cancer

China
Shanghai Chest Hospital
SOTIO a.s.

Unknown

Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

Non Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Suspended

Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

China
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation

Non-small-cell Lung Cancer

China
Peking University People's Hospital

Unknown

VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Fudan University

Completed

Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Protgen Ltd

Unknown

Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer

Non Small Cell Lung Cancer

China
Simcere Pharmaceutical Co., Ltd
Daping Hospital and the Research Institute of Surgery of the Third Military...

Unknown

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Third Military Medical University

Unknown

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Third Military Medical University

Unknown

Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC) (DO201001)

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Squamous Cell Lung Cancer

China
Fudan University

Recruiting

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

Small Cell Lung Cancer Extensive Stage

China
Guangzhou Gloria Biosciences Co., Ltd.

Not yet recruiting

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

Advanced Non-Small-Cell Lung Cancer

China
Hutchison Medipharma Limited

Recruiting

Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients

Non-small Cell Lung Cancer Metastatic

China
Peking Union Medical College Hospital

Recruiting

Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)

Advanced Non-small Cell Lung Cancer

China
Daping Hospital and the Research Institute of Surgery...
First Affiliated Hospital of Chongqing Medical University

Completed

PPIO-006 Primary Tumor Resection for IVa NSCLC

Non-small-cell Lung Cancer (NSCLC)

China
Lee's Pharmaceutical Limited

Completed

A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

Extensive-stage Small-cell Lung Cancer

China
Shanghai Chest Hospital

Active, not recruiting

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Extensive-Stage Small-Cell Lung Cancer

China
Akeso

Active, not recruiting

AK112 in Advanced Non-Small Cell Lung Cancer

Advanced Non-small-cell Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
G1 Therapeutics, Inc.

Completed

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Extensive-Stage Small Cell Lung Cancer Patients Receiving Carboplatin Combined With Etoposide or Topotecan

Extensive-stage Small-cell Lung Cancer

China
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Terminated

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Advanced Non-small Cell Lung Cancer

China
Tianjin Medical University Second Hospital

Unknown

A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Small Cell Lung Cancer Extensive Stage

China
Peking University People's Hospital
National Natural Science Foundation of China

Completed

Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients

Carcinoma | Lung Neoplasms | Non-small-cell Lung Cancer

China
Junling Li

Unknown

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Extensive-Stage Small Cell Lung Cancer

China
Chinese PLA General Hospital

Unknown

Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer

China
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Completed

Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC

Advanced Lung Cancer

China
Shanghai Zhongshan Hospital

Completed

Comparison of Different Ventilation Mode During One-lung Ventilation

Ventilator-Induced Lung Injury | Thoracic Surgery | One Lung Ventilation

China
Peking Union Medical College Hospital
Merck Sharp & Dohme LLC; BeyondSpring Pharmaceuticals Inc.

Recruiting

Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) (KeyPemls-004)

Non Small Cell Lung Cancer Metastatic

China
Shanghai Chest Hospital

Not yet recruiting

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

NRG1-fused Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

Small-cell Lung Cancer | Neoadjuvant Therapy

China
Shanghai Institute Of Biological Products
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer

Non-squamous Non-small-cell Lung Cancer

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

NSCLC | Neoadjuvant Therapy

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital
Allist Pharmaceuticals, Inc.

Recruiting

Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC (FOCUS-A)

Non-Small-Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

Non Small Cell Lung Cancer

China
AnHeart Therapeutics Inc.

Active, not recruiting

A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

Non Small Cell Lung Cancer

China

3

Subscribe